Stamos Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextEra Energy
NEE
|
+$4.1M |
| 2 |
Blackrock
BLK
|
+$3.69M |
| 3 |
Pfizer
PFE
|
+$3.44M |
| 4 |
Canadian National Railway
CNI
|
+$3.19M |
| 5 |
GSK
GSK
|
+$3.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$7.38M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.77M |
| 3 |
Citigroup
C
|
+$4.52M |
| 4 |
Intel
INTC
|
+$2.98M |
| 5 |
Cisco
CSCO
|
+$2.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.05% |
| 2 | Energy | 14.82% |
| 3 | Technology | 11.49% |
| 4 | Financials | 10.42% |
| 5 | Communication Services | 6.12% |
Similar funds
Stamos Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Stamos Capital Partners held 134 positions worth $426M, up 0.28% from $425M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Stamos Capital Partners deployed $18.5M of net new capital in Q4 2024, opening 7 new positions and adding to 78 existing holdings. Its largest new stake was Blackrock: 3,640 shares worth $3.73M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $6.77M trimmed.
- Stamos Capital Partners's largest Q4 2024 buy was Blackrock: 3,640 shares worth $3.73M.
- Stamos Capital Partners added most to NextEra Energy in Q4 2024, an estimated $4.1M increase.
- Stamos Capital Partners's biggest Q4 2024 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $6.77M.
- Stamos Capital Partners fully exited Walgreens Boots Alliance in Q4 2024, selling an estimated $7.38M.
- Stamos Capital Partners's ten largest holdings make up 38% of its $426M portfolio in Q4 2024.
- Stamos Capital Partners opened 7 new positions and closed 8 in Q4 2024.
- Stamos Capital Partners's portfolio value rose 0.28% quarter-over-quarter to $426M.
Based on Stamos Capital Partners's 13F filing for Q4 2024, filed 13 Feb 2025.